Warnings for fluoxetine. Below are some factors you may want to discuss with your doctor before taking fluoxetine oral capsule. Boxed warning: Risk of
Fluoxetine (Prozac). GENERAL DRUG INFORMATION. Fluoxetine is a selective WARNINGS/CONTRAINDICATIONS: Fluoxetine should be used with caution in
Pediatric Use of Fluoxetine Fluoxetine is approved for use in pediatric patients with MDD and OCD [see Box Warning and Warnings and Precautions ]. Limited evidence is available concerning the longer-term effects of fluoxetine on the development and maturation of children and adolescent patients.
Learn more about some of the side effects fluoxetine oral capsules may cause. Boxed warning. Fluoxetine oral capsules have boxed warnings. Can stopping fluoxetine lead to withdrawal symptoms?
use of pimozide and fluoxetine [see Contraindications (4.2), Warnings and Precautions fluoxetine has been discontinued [see Contraindications (4.2)].
This is why you should ask your healthcare provider before taking Fluoxetine and Duloxetine together. What are the warnings associated with the use of Fluoxetine and Duloxetine together? A few warnings have been issued to ensure the safe and effective use of Fluoxetine and Duloxetine together. These include: Suicidal warning
Learn more about some of the side effects fluoxetine oral capsules may cause. Boxed warning. Fluoxetine oral capsules have boxed warnings. Can stopping fluoxetine lead to withdrawal symptoms?
Pediatric Use of fluoxetine Fluoxetine is approved for use in pediatric patients with MDD and OCD [see Box Warning and Warnings and Precautions (5.1)]. Limited evidence is available concerning the longer-term effects of fluoxetine on the development and maturation of children and adolescent patients.
Pediatric Use of Fluoxetine Fluoxetine is approved for use in pediatric patients with MDD and OCD [see Box Warning and Warnings and Precautions ]. Limited evidence is available concerning the longer-term effects of fluoxetine on the development and maturation of children and adolescent patients.
Comments